Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
通过共同创建对话代理来帮助人们坚持伐尼克兰治疗：可行性研究
批准号：
486393
负责人：
Hafuth Sowsan
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
中文摘要
翻译
大约320万加拿大人吸烟，除非他们戒烟，大约一半的人会死于吸烟（Samet, 2013）。伐尼克兰是最有效的戒烟药物（Cahill et al., 2013）。不幸的是,
英文摘要
Approximately 3.2 million Canadians smoke tobacco and unless they quit smoking, about half of them will die due to their smoking (Samet, 2013). Varenicline is the most effective medication to help someone quit smoking (Cahill et al., 2013). Unfortunately,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Building a healthbot to help people adhere to their varenicline prescriptions using patient perspectives: a feasibility trial
-
批准号：493338
-
项目类别：
-
资助金额：$0.11万
-
财政年份：2023
-
负责人：Hafuth Sowsan
-
依托单位：
海外基金
